Society Partnerships Conexiant’s established access to oncology clinicians through ASCO, NCCN and APSHO, along with a growing collaboration with the American Dental Association, creates a compelling channel for pharma, device manufacturers and service providers to sponsor content, education programs and events that reach clinicians across specialties.

Acquisition Momentum The 2023 Texere Publishing acquisition expands B2B media reach into the UK, Europe and the US, enabling multiregional campaigns and cross-sell of content platforms and product solutions to a broader set of audiences.

Digital Platform Readiness A disciplined tech stack including consent management and developer friendly tools suggests readiness to host scalable digital education platforms, compliant marketing programs and data driven campaigns for pharma and life sciences clients.

Lean Growth Potential With revenue in the 10 to 25 million range and a lean team, Conexiant can scale high value sponsorships, content licensing and events by expanding partnerships and entering new societies and segments.

Cross Specialty Expansion Recent dental market partnerships and oncology content leadership point to cross specialty opportunities to package combined education experiences and advertising packages that span oncology and dental clinicians, attracting pharma and device brands seeking broader reach.